A detailed history of Amalgamated Bank transactions in 908 Devices Inc. stock. As of the latest transaction made, Amalgamated Bank holds 766 shares of MASS stock, worth $2,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares
766
Previous 766 -0.0%
Holding current value
$2,780
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$6.55 - $9.92 $6,510 - $9,860
-994 Reduced 56.48%
766 $6,000
Q4 2023

Feb 06, 2024

SELL
$4.96 - $12.41 $1,130 - $2,829
-228 Reduced 11.47%
1,760 $20,000
Q2 2023

Aug 11, 2023

SELL
$5.78 - $10.02 $2,774 - $4,809
-480 Reduced 19.45%
1,988 $13,000
Q1 2023

May 02, 2023

SELL
$6.61 - $10.66 $3,186 - $5,138
-482 Reduced 16.34%
2,468 $21,000
Q3 2022

Nov 09, 2022

BUY
$15.18 - $24.99 $182 - $299
12 Added 0.41%
2,950 $49,000
Q2 2022

Aug 15, 2022

SELL
$13.3 - $20.74 $1,463 - $2,281
-110 Reduced 3.61%
2,938 $60,000
Q1 2022

Jun 30, 2022

BUY
$13.18 - $26.28 $40,172 - $80,101
3,048 New
3,048 $58,000

Others Institutions Holding MASS

About 908 Devices Inc.


  • Ticker MASS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,590,200
  • Market Cap $115M
  • Description
  • 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...
More about MASS
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.